Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$15.36 - $27.51 $88,995 - $159,392
-5,794 Reduced 35.47%
10,540 $261,000
Q1 2022

May 12, 2022

SELL
$22.22 - $39.12 $28,886 - $50,856
-1,300 Reduced 7.37%
16,334 $409,000
Q4 2021

Feb 11, 2022

SELL
$18.38 - $40.5 $314,702 - $693,441
-17,122 Reduced 49.26%
17,634 $642,000
Q3 2021

Nov 12, 2021

BUY
$13.18 - $19.83 $52,720 - $79,320
4,000 Added 13.01%
34,756 $594,000
Q2 2021

Aug 13, 2021

BUY
$9.59 - $50.88 $294,950 - $1.56 Million
30,756 New
30,756 $411,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.